NCT02473445 - A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 19, 2015

Primary Completion Date

March 6, 2017

Study Completion Date

March 6, 2017

Conditions

Mitochondrial Diseases

Interventions

DRUG

Cysteamine Bitartrate

Cysteamine Bitartrate Delayed-release capsules

Trial Locations (5)

Akron Children's Hospital, Akron

Baylor College of Medicine, Houston

University of Utah, Salt Lake City

Stanford University School of Medicine, Stanford

University of California at San Diego (UCSD), San Diego